These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12921608)

  • 21. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms.
    Galli A; Ceni E; Crabb DW; Mello T; Salzano R; Grappone C; Milani S; Surrenti E; Surrenti C; Casini A
    Gut; 2004 Nov; 53(11):1688-97. PubMed ID: 15479693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of NK4 gene transfection on tumor growth of human pancreatic cancer xenograft in nude mice].
    Lai RX; Zhang SN; Nakamura T; Yuan SZ
    Ai Zheng; 2005 Oct; 24(10):1191-5. PubMed ID: 16219131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma.
    Nishida K; Furumatsu T; Takada I; Kawai A; Yoshida A; Kunisada T; Inoue H
    Br J Cancer; 2002 Apr; 86(8):1303-9. PubMed ID: 11953889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H
    Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process.
    Pavan L; Tarrade A; Hermouet A; Delouis C; Titeux M; Vidaud M; Thérond P; Evain-Brion D; Fournier T
    Carcinogenesis; 2003 Aug; 24(8):1325-36. PubMed ID: 12807721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thyroid hormone inhibits the growth of pancreatic cancer xenograft in nude mice].
    Wang N; Shang B; Shi H; Ma H; Jiang J; Qin B; Dong L
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Aug; 33(8):1160-4. PubMed ID: 23996757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
    Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells.
    Wang Z; Shen W; Li X; Feng Y; Qian K; Wang G; Gao Y; Xu X; Zhang S; Yue L; Cao J
    Drug Des Devel Ther; 2020; 14():3099-3110. PubMed ID: 32801648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
    Chen ZY; Tseng CC
    Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.
    Yamamoto Y; Fujita M; Koma H; Yamamori M; Nakamura T; Okamura N; Yagami T
    Biochem Biophys Res Commun; 2011 Jul; 410(3):563-7. PubMed ID: 21683069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
    Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
    Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoid X receptor alpha (RXRα) and peroxisome proliferator-activated receptor gamma (PPARγ) expression in breast cancer: an immunohistochemical study.
    Ditsch N; Vrekoussis T; Lenhard M; Rühl I; Gallwas J; Weissenbacher T; Friese K; Mayr D; Makrigiannakis A; Jeschke U
    In Vivo; 2012; 26(1):87-92. PubMed ID: 22210720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor-alpha exert synergistic antiproliferative effects on human coronary artery smooth muscle cells.
    Benson S; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Mol Cell Biol Res Commun; 2000 Mar; 3(3):159-64. PubMed ID: 10860864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experimental study on anti-metastasis effect of emodin on human pancreatic cancer].
    Liu A; Sha L; Shen Y; Huang L; Tang X; Lin S
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(22):3167-71. PubMed ID: 22375400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
    Allred CD; Kilgore MW
    Mol Cell Endocrinol; 2005 May; 235(1-2):21-9. PubMed ID: 15866424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells.
    Koga H; Selvendiran K; Sivakumar R; Yoshida T; Torimura T; Ueno T; Sata M
    Int J Oncol; 2012 Mar; 40(3):679-85. PubMed ID: 22020928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.